(Stroke. 1999;30:126-133.)
© 1999 American Heart Association, Inc.
Original Contributions |
Osteogenic Protein-1 Protects Against Cerebral Infarction Induced by MCA Ligation in Adult Rats
From the Department of Pharmacology and Neurosurgery, National Defense Medical Center, Taipei, Taiwan (S.-Z.L., Y.W.); the Department of Pharmacology, University of Colorado Health Sciences Center, Denver (B.J.H.); and Creative Biomolecules, Inc, Boston, Mass (P.K.).
Correspondence to Yun Wang, MD, PhD, National Institute on Drug Abuse, IRP, 5500 Nathan Shock Dr, Baltimore, MD 21224. E-mail ywang@intra.nida.nih.gov; yunwang{at}ms3.hinet.net
Background and Purpose—Osteogenic protein-1 (OP1) not only possesses trophic activity on bone tissue but also influences neuronal survival and differentiation in vitro. Specific receptors for OP1 are present in brain and spinal cord and can be upregulated during cerebral contusion. OP1 is a member of the transforming growth factor-ß superfamily, several of whose members possess neuroprotective activity. In this study, the neuroprotective effect of OP1 in cerebral ischemia was evaluated in adult animals.
Methods—Adult male Sprague-Dawley rats were anesthetized with chloral hydrate. OP1 or vehicle was administered intracortically or intracerebroventricularly to the rats. Thirty minutes, 24 hours, or 72 hours after OP1 injection, the right middle cerebral artery (MCA) was ligated for 90 minutes. Twenty-four hours after reperfusion, animals were tested for motor behavior. The animals were subsequently anesthetized with urethane and perfused intracardially with saline. Brain tissue was removed, sliced, and incubated with 2% triphenyltetrazolium chloride to localize the area of infarction.
Results—Only animals pretreated with OP1 24 hours before MCA ligation showed a reduction in motor impairment. OP1, given 30 minutes or 72 hours before MCA ligation, did not reduce cortical infarction. In contrast, pretreatment with OP1 24 hours before MCA ligation significantly attenuated the volume of infarction in the cortex, in agreement with the behavioral findings.
Conclusions—Intracerebral administration of OP1 24 hours before MCA ligation reduces ischemia-induced injury in the cerebral cortex.
Editorial Comment
Department of Neurology, Cerebrovascular Disease Section, Washington University School of Medicine, St Louis, Missouri
This article has been cited by other articles:
 |
|
 |
|
  W.-C. Shyu, S.-Z. Lin, P.-S. Yen, C.-Y. Su, D.-C. Chen, H.-J. Wang, and H. Li Stromal Cell-Derived Factor-1{alpha} Promotes Neuroprotection, Angiogenesis, and Mobilization/Homing of Bone Marrow-Derived Cells in Stroke Rats J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 834 - 849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-C. Shyu, S.-Z. Lin, M.-F. Chiang, D.-C. Ding, K.-W. Li, S.-F. Chen, H.-I Yang, and H. Li Overexpression of PrPC by Adenovirus-Mediated Gene Targeting Reduces Ischemic Injury in a Stroke Rat Model J. Neurosci., September 28, 2005; 25(39): 8967 - 8977. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-F. Chang, S.-Z. Lin, Y.-H. Chiang, M. Morales, J. Chou, P. Lein, H.-L. Chen, B. J. Hoffer, and Y. Wang Intravenous Administration of Bone Morphogenetic Protein-7 After Ischemia Improves Motor Function in Stroke Rats Stroke, February 1, 2003; 34(2): 558 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, C.-F. Chang, M. Morales, J. Chou, H.-L. Chen, Y.-H. Chiang, S.-Z. Lin, J. L. Cadet, X. Deng, J.-Y. Wang, et al. Bone Morphogenetic Protein-6 Reduces Ischemia-Induced Brain Damage in Rats Stroke, September 1, 2001; 32(9): 2170 - 2178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fisher and W. Schaebitz An Overview of Acute Stroke Therapy: Past, Present, and Future Arch Intern Med, November 27, 2000; 160(21): 3196 - 3206. [Full Text] [PDF]
|
|